Michael Morer

Michael Morer has a diverse work experience in the pharmaceutical industry. Michael currently serves as the Global Brand Lead Hematology at Sobi - Swedish Orphan Biovitrum AB (publ) since April 2023. Prior to that, they worked as a Regional Team Leader, Hematology Oncology at Roche Pharma AG from May 2021 to January 2023. From January 2019 to May 2021, they held the position of Integrated Strategy Lead (iSL) Hematology at Roche Pharma AG Germany. Before that, they worked briefly as the Deputy Director Strategic Marketing GI cancers (Stivarga, Nexavar) at Bayer Pharmaceuticals from October 2018 to December 2018. From 2009 to 2018, they held multiple roles at Roche including International Product Manager TECENTRIQ, Sales Representative Oncology Hematology, Product Manager Herceptin, and Product Manager MabThera. Michael also worked as a Business Analyst Hematology at Roche from February 2008 to July 2008. Prior to that, they worked at Sanofi-aventis as an International Product Manager and Product Manager OTC in 2007 and 2006 respectively.

Michael Morer completed a Doctor of Pharmacy (PharmD) degree in Pharmaceutical Sciences from Université de Bordeaux in 2008, after completing their Master's Degree in Marketing Management from ESSEC Business School in 2009. Michael also holds a certification in "Leading Your Team Through Change" from LinkedIn, obtained in 2020.